Back to search

Article

Pan-active imidazolopiperazine antimalarials target the <i>Plasmodium falciparum</i> intracellular secretory pathway

2019-08-15

Abstract excerpt

<h4> A bstract </h4> One of the most promising new compound classes in clinical development for the treatment of malaria is the imidazolopiperazines (IZPs) class. Human trials have demonstrated that members of the IZP series, which includes KAF156 (Ganaplacide) and GNF179, are potent and effective against Plasmodium symptomatic asexual blood-stage infections. Unlike other commonly used antimalarials, they also...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
db971877-5839-5a4e-8b98-2c3c548852ac
DOI
10.1101/735894
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pan-active imidazolopiperazine antimalarials target the <i>Plasmodium falciparum</i> intracellular secretory pathwayDOI 10.1101/735894
Select a neighboring publication to make it the new centre.